Beta-adrenergic agents have a direct relaxing effect on bronchial smooth muscle. In vitro investigations of a number of sensitized preparations have demonstrated an inhibition of the antigen-induced histamine release. Grass pollen allergic patients were pretreated in the laboratory, out of the season, with different dosages of intranasal fenoterol before an allergen challenge and hay-fever patients treated with fenoterol during the season in a clinical trial. The laboratory studies demonstrated a moderate and significant (p less than 0.01) inhibitory effect on the immediate allergen-induced symptoms, suggesting an action on mediator release from mast cells. Fenoterol had only a slight, although significant (p less than 0.05), effect on nasal symptoms in the clinical study. In conclusion, fenoterol seems to have an anti-allergic effect, when applied to the airway mucosa, but the effect on allergic rhinitis does not seem sufficient to justify the introduction of fenoterol as a nasal spray.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fenoterol
6
anti-allergic beta
4
beta 2-adrenergic
4
2-adrenergic agent
4
agent fenoterol
4
fenoterol nose
4
nose beta-adrenergic
4
beta-adrenergic agents
4
agents direct
4
direct relaxing
4

Similar Publications

Phenylacetylglycine (PAGly) is a small molecule derived from phenylalanine in the gut glycine degradation and conjugation. It has been associated with both the progression of atherosclerosis and protective effects on the myocardium. This study evaluated the function and the underlying mechanisms of PAGly in a rat cerebral ischemia/reperfusion (I/R) injury model.

View Article and Find Full Text PDF

Biased agonism in G protein-coupled receptors is a phenomenon resulting in the selective activation of distinct intracellular signaling pathways by different agonists, which may exhibit bias toward either Gs, Gi, or arrestin-mediated pathways. This study investigates the structural basis of ligand-induced biased agonism within the context of the β-adrenergic receptor (β-AR). Atomistic molecular dynamics simulations were conducted for β-AR complexes with two stereoisomers of methoxynaphtyl fenoterol (MNFen), that is, compounds eliciting qualitatively different cellular responses.

View Article and Find Full Text PDF
Article Synopsis
  • Asthma and COPD are common respiratory issues, and a new combination drug of Ipratropium and Fenoterol has been developed for symptom management.
  • Researchers created three innovative, cost-effective spectrophotometric methods to accurately measure these drugs together in their inhaler form, using water as a green solvent and eliminating separation steps.
  • These methods involve various approaches, such as zero-order absorption and ratio spectrum techniques, successfully addressing challenges in detecting Ipratropium and proving effective across specific concentration ranges according to industry guidelines.
View Article and Find Full Text PDF

Ipratropium bromide (IPR) and fenoterol hydrobromide (FEN) have recently been combined in a promising inhaler to treat two prevalent inflammatory illnesses of the airways: bronchial asthma and chronic obstructive pulmonary disease (COPD). The necessity for a single, sensitive, and trustworthy analytical approach to cover the diverse and necessary tests of in-vitro and in-vivo studies is greatly grown with the rising production of new fixed combinations. Two novel, selective and environmentally friendly LC techniques were developed in order to guarantee precise measurement of IPR and FEN in their challenging formulation.

View Article and Find Full Text PDF

Air pollution from diesel combustion is linked in part to the generation of diesel exhaust particles (DEP). DEP exposure induces various processes, including inflammation and oxidative stress, which ultimately contribute to a decline in lung function. Cyclic AMP (cAMP) signaling is critical for lung homeostasis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!